Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China

RecruitingOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

April 24, 2025

Primary Completion Date

June 30, 2031

Study Completion Date

June 30, 2031

Conditions
AORTIC VALVE DISEASESBicuspid Aortic Valve (BAV)
Interventions
PROCEDURE

Transcatheter Aortic Valve Replacement (TAVR)

TAVR procedure was performed according to standard clinical practice. Successful vascular access, delivery and deployment of the device and successful retrieval of the delivery system will be attempted. Vascular access site will be through transfemoral on the basis of pre-procedural evaluation of access site vessel. The procedure will be performed under local or general anesthesia and per clinical practice standard.

Trial Locations (4)

710032

RECRUITING

Department of Cardiovascular Surgery of Xijing Hospital, Air Force Military Medical University, Xi'an

Unknown

NOT_YET_RECRUITING

West China Hospital, Sichuan University, Chengdu

NOT_YET_RECRUITING

Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing

RECRUITING

Shanghai Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

Fu Wai Hospital, Beijing, China

OTHER

collaborator

West China Hospital

OTHER

lead

Xijing Hospital

OTHER